News & Updates
Showing Multidisciplinary articles
Showing

Orforglipron: The new kid on the weight loss runway?
The novel oral, non-peptide glucagon-like peptide-1 receptor agonist (GLP-1 RA) orforglipron gains the upper hand over the current leading oral GLP-1 RA, semaglutide, in individuals with type 2 diabetes (T2D) inadequately controlled on metformin in the phase III ACHIEVE-3 study.
Orforglipron: The new kid on the weight loss runway?
31 Mar 2026
CKD patients more prone to tuberculosis
Patients with stage 5 chronic kidney disease (CKD5) are at greater risk of developing tuberculosis (TB) than the general population, especially if they are male or receiving dialysis, suggests a Singapore study.
CKD patients more prone to tuberculosis
30 Mar 2026
Antibiotics, low-yield investigations for recurrent UTI prevail in real-world practice
Recurrent urinary tract infection (UTI) care in primary and secondary care settings appears to be characterized by low guideline adherence, with a substantial number of women still being treated with antibiotics and subjected to low-yield investigations, according to a study.






